Hero MotoCorp (NSE: HEROMOTOCO) May dispatches rise to 5.7 lakh units as VIDA and exports sharpen growth story
Read More Pharma Industry News Stargardt disease pipeline shifts as Belite Bio clears enrollment risk for tinlarebant Discover why Belite Bio’s DRAGON II enrollment milestone shifts Stargardt disease drug development and what it means for investors and regulators. bySoujanya RaviJanuary 30, 2026